Version 2.5.2.0 CRISP Logo CRISP Homepage Help for CRISP Email Us

Abstract

Grant Number: 1R43ES016395-01
Project Title: Biomarkers of Response to Environmental Stressors: Measurement of Environmental E
PI Information:NameEmailTitle
BIRNBAUM, EVA R. eva@caldera-pharmaceuticals.com

Abstract: DESCRIPTION (provided by applicant) Caldera Pharmaceutical's will use their unique, R&D100-award-winning Reagentless Pharmacoproteomic Measurement (RPM) high-throughput technology to identify biomarkers of response to environmental stressors (BRES). Caldera developed RPM in collaboration with Los Alamos National Laboratory. RPM allows the identification and measurement of BRES consisting of protein-metal adducts and metabolites. We propose to develop BRES to define patterns of response to benefit the Gene Environment Initiative, focusing on xenobiotic biotransformation in human disease like Autism. Our BRES will lead to reliable measurements of exposures, which can be correlated with variable susceptibility to metal toxicity in the human population. This provides valuable information involving metabolic pathways for the Gene Environment Initiative (GEI). We will measure exposure to metal stressors in biospecimens by developing BRES that can identify exposure to particular chemical forms of toxic metals. Protein:metal adducts formed in individual patients may be correlated to genetic differences regulating metallothionein or other metallome proteins thought to be related to autism. RPM can monitor simultaneous exposure to toxins, such as arsenic, cadmium, lead, and mercury (thimerasol), as well as exposure to essential metals (zinc, iron, selenium, etc.). Individuals with autism may have varying genes that biotransform and detoxify metals differently, leading to varying accumulation and disease susceptibility.

Thesaurus Terms:
biomarker, environmental exposure, environmental stressor, heavy metal
biotransformation, gene environment interaction, immunologic assay /test, ligand, metabolism, method development, protein protein interaction
clinical research, high throughput technology, proteomics

Institution: CALDERA PHARMACEUTICALS, INC.
LOS ALAMOS, NM 87544
Fiscal Year: 2007
Department:
Project Start: 15-SEP-2007
Project End: 31-AUG-2008
ICD: NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES
IRG: ZES1


CRISP Homepage Help for CRISP Email Us